Aurinia Pharmaceuticals

AUPH NASDAQ
Overview Stats Financials News

Price & Volume

Stats

See more
52W Range $4.71-$12.43
Market Cap $808M
Shares Short 9M

Financials

See more
Revenue (12 Mos) $191.4M
Revenue Growth (YoY) 46.2%
Gross Profit (12 Mos) $83.3M
Diluted EPS -$0.43

About

CEO Mr. Peter S. Greenleaf M.B.A.
Address 118 Avenue , 14315, Edmonton, AB, Canada, T5L 4S6
Sector Healthcare
Industry Biotechnology
Full-Time Employees 300